CD274 and diffuse large B-cell lymphoma: Previous studies focusing on the PD ligand‐1 (PD‐L1) in DLBCL patients have revealed that DLBCL patients showed significantly higher plasma‐soluble PD‐L1 than in healthy volunteers 15, 16.